@MD_pause That was exactly my question, USCIS handles million of cases and different categories - and a lot of newly matched residents are now researchers until they begin their residency, so how can USCIS identify their cases !!
Our lab is expanding and hiring both a postdoc and staff scientist! We study how metabolism and cell cycle states drive tumor progression, therapy response, and immune interactions. Philly is a great place to live and do research! See more at: https://t.co/Qptg5QHh66.
Stunning contrast between flat urothelial carcinoma in situ (right side of each image) and reactive urothelium (left side)
CIS➡️enlarged, irregular, & hyperchromatic nuclei
Reactive➡️small, uniform nuclei w/vesicular chromatin + intraepithelial acute & chronic inflammation
Huge thank you to our panelists for sharing their insight and their time! The video for this event has been uploaded to our Youtube! Check it out: https://t.co/IcMbKZ3qoP
🚨🔬 Our favorite week in Surg Path is back! Join MGH & Harvard Med for the 46th Current Concepts in Surgical Pathology—live, virtual, and packed with practical pearls. Real cases, lively Q&A, and faculty you know & love.
Save your seat 👇
Proud to see our work published in Nature 🎊
The study presents the first oral macrocyclic peptide inhibitors that block cyclin A/B–RxL interactions, trigger apoptosis in Small Cell Lung Cancer with high E2F activity, showing efficacy in preclinical models.
https://t.co/kc7sDOQgF1
Enjoy collection of current and future lectures in this playlist of my YouTube channel, given by friends in memory of dear friend, visionary, leader, and educator late Dr. Sambit Mohanty. https://t.co/4jsvdR0rpj
My poster at #USCAP25!
Grateful for the chance to share our work from @MGBpathology and connect with amazing pathologists!
Big thanks to everyone who stopped by and shared valuable feedback, I truly appreciated the discussions and support!
Already excited for USCAP26 in San Antonio!